D
Creative Medical Technology Holdings, Inc. CELZ
$2.21 -$0.07-3.07% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2025 09/30/2025 06/30/2025 03/31/2025 12/31/2024
Net Income -1.81% -18.83% 20.83% -57.28% -10.46%
Total Depreciation and Amortization 36.73% 6.14% 4.78% 4.44% -11.37%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -117.39% -100.00% -100.00% -61.96% 136.95%
Change in Net Operating Assets 37.78% 125.47% -12.40% -88.23% 41.34%
Cash from Operations 0.61% -18.57% 21.14% -77.44% -2.88%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- -100.00%
Cash from Investing -- -- -- -- -100.00%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 133.86% -- -- -- --
Repurchase of Common Stock -- 100.00% 100.00% 87.92% 100.00%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 134.47% 100.00% 100.00% 4,150.72% 2,157.45%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 672.69% 3.50% 24.56% -68.19% 69.24%